Records Management

PRODUCTS

  • Allogeneic CAR-T Cells Vs Autologous

    Chimeric antigen receptor (CAR) T cell therapy has emerged as one of the major breakthroughs in cancer immunotherapy in the last decade. Clinical trials with autologous CAR-T cells have shown very promising results and led to the approval of numerous CAR-T cell therapies.

  • Ensure the safety and efficacy of your mRNA therapeutics with high-quality, GMP-grade reagents from a trusted partner with a multi-tiered quality approach to deliver manufacturing certainty.

  • Optimize your line efficiency with accumulation between the upstream and downstream machines. Our accumulators let you decouple two machines, meaning you can run different equipment at varying speeds while still maintaining balance in the event of upstream or downstream stoppages.

  • Optical filters enhance system precision by selectively transmitting or blocking wavelengths, supporting machine vision, spectroscopy, fluorescence microscopy, and medical imaging with customizable solutions.

  • Neither traditional nor hybrid clinical trials can operate on rigid EDC systems.

    They require flexible data collection systems that support protocol amendments without downtime and accept mobile data without hassle. As a cloud-native solution, TrialKit bends to accommodate mid-study changes. And as the first full-featured EDC platform available as a native mobile app, TrialKit flexes to meet the demands of traditional, hybrid/decentralized, and completely remote clinical trials.

    Give your team the freedom to build, deploy, and manage their studies, their way—weeks faster than with rigid EDCs and for a fraction of the cost of the major players.

WHITE PAPERS AND CASE STUDIES

NEWS